- Home
- PAGS vs GLPG Comparison
PAGS vs GLPG Comparison
Compare PAGS & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGS
- GLPG
- Stock Information
- Founded
- PAGS 2006
- GLPG 1999
- Country
- PAGS Brazil
- GLPG Belgium
- Employees
- PAGS N/A
- GLPG N/A
- Industry
- PAGS EDP Services
- GLPG Biotechnology: Pharmaceutical Preparations
- Sector
- PAGS Technology
- GLPG Health Care
- Exchange
- PAGS Nasdaq
- GLPG Nasdaq
- Market Cap
- PAGS 2.3B
- GLPG 2.1B
- IPO Year
- PAGS N/A
- GLPG 2005
- Fundamental
- Price
- PAGS $10.20
- GLPG $32.06
- Analyst Decision
- PAGS Buy
- GLPG Sell
- Analyst Count
- PAGS 6
- GLPG 4
- Target Price
- PAGS $12.17
- GLPG $25.33
- AVG Volume (30 Days)
- PAGS 4.4M
- GLPG 184.7K
- Earning Date
- PAGS 11-12-2025
- GLPG 10-29-2025
- Dividend Yield
- PAGS 1.44%
- GLPG N/A
- EPS Growth
- PAGS 20.55
- GLPG N/A
- EPS
- PAGS 1.30
- GLPG N/A
- Revenue
- PAGS $3,543,799,551.00
- GLPG $323,674,692.00
- Revenue This Year
- PAGS $19.16
- GLPG N/A
- Revenue Next Year
- PAGS $6.56
- GLPG N/A
- P/E Ratio
- PAGS $7.36
- GLPG N/A
- Revenue Growth
- PAGS 14.53
- GLPG 5.43
- 52 Week Low
- PAGS $6.11
- GLPG $22.36
- 52 Week High
- PAGS $10.21
- GLPG $33.86
- Technical
- Relative Strength Index (RSI)
- PAGS 71.11
- GLPG 51.64
- Support Level
- PAGS $9.20
- GLPG N/A
- Resistance Level
- PAGS $9.87
- GLPG $33.63
- Average True Range (ATR)
- PAGS 0.30
- GLPG 0.60
- MACD
- PAGS 0.09
- GLPG -1.23
- Stochastic Oscillator
- PAGS 97.80
- GLPG 95.33
About PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
About GLPG Galapagos NV
Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.